UTZ vs. MED, FARM, JVA, TTCFQ, MKC, SCI, CHWY, COKE, COTY, and PPC
Should you be buying Utz Brands stock or one of its competitors? The main competitors of Utz Brands include Medifast (MED), Farmer Bros. (FARM), Coffee (JVA), Tattooed Chef (TTCFQ), McCormick & Company, Incorporated (MKC), Service Co. International (SCI), Chewy (CHWY), Coca-Cola Consolidated (COKE), Coty (COTY), and Pilgrim's Pride (PPC).
Medifast (NYSE:MED) and Utz Brands (NYSE:UTZ) are both consumer staples companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, risk, earnings, analyst recommendations, institutional ownership, valuation, dividends, profitability and community ranking.
In the previous week, Medifast had 2 more articles in the media than Utz Brands. MarketBeat recorded 6 mentions for Medifast and 4 mentions for Utz Brands. Medifast's average media sentiment score of 1.26 beat Utz Brands' score of -0.25 indicating that Utz Brands is being referred to more favorably in the news media.
Medifast has higher earnings, but lower revenue than Utz Brands. Utz Brands is trading at a lower price-to-earnings ratio than Medifast, indicating that it is currently the more affordable of the two stocks.
Medifast received 332 more outperform votes than Utz Brands when rated by MarketBeat users. Likewise, 63.83% of users gave Medifast an outperform vote while only 60.00% of users gave Utz Brands an outperform vote.
95.5% of Medifast shares are owned by institutional investors. Comparatively, 96.0% of Utz Brands shares are owned by institutional investors. 2.5% of Medifast shares are owned by insiders. Comparatively, 17.0% of Utz Brands shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Medifast has a beta of 1.16, meaning that its stock price is 16% more volatile than the S&P 500. Comparatively, Utz Brands has a beta of 0.99, meaning that its stock price is 1% less volatile than the S&P 500.
Medifast currently has a consensus target price of $49.75, indicating a potential upside of 127.69%. Utz Brands has a consensus target price of $20.42, indicating a potential upside of 9.62%. Given Utz Brands' higher probable upside, analysts clearly believe Medifast is more favorable than Utz Brands.
Medifast has a net margin of 7.55% compared to Medifast's net margin of -1.38%. Utz Brands' return on equity of 36.64% beat Medifast's return on equity.
Summary
Medifast beats Utz Brands on 11 of the 18 factors compared between the two stocks.
Get Utz Brands News Delivered to You Automatically
Sign up to receive the latest news and ratings for UTZ and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding UTZ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Utz Brands Competitors List
Related Companies and Tools